These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 15522036

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antibacterial drug discovery: is small pharma the solution?
    Boggs AF, Miller GH.
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():32-6. PubMed ID: 15522038
    [Abstract] [Full Text] [Related]

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. An overview of the pharmaceutical industry.
    Stave GM, Joines R.
    Occup Med; 1997 Dec; 12(1):1-4. PubMed ID: 9153049
    [Abstract] [Full Text] [Related]

  • 9. The abandonment of antibacterials: why and wherefore?
    Shlaes DM.
    Curr Opin Pharmacol; 2003 Oct; 3(5):470-3. PubMed ID: 14559090
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ, Bradford PA.
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [Abstract] [Full Text] [Related]

  • 13. Antibiotic development: a victim of market forces?
    Tillotson GS.
    IDrugs; 2008 May; 11(5):340-6. PubMed ID: 18465675
    [Abstract] [Full Text] [Related]

  • 14. Nature's clarion call of antibacterial resistance: are we listening?
    Theuretzbacher U, Toney JH.
    Curr Opin Investig Drugs; 2006 Feb; 7(2):158-66. PubMed ID: 16499286
    [Abstract] [Full Text] [Related]

  • 15. Challenges of antibacterial discovery revisited.
    Gwynn MN, Portnoy A, Rittenhouse SF, Payne DJ.
    Ann N Y Acad Sci; 2010 Dec; 1213():5-19. PubMed ID: 21058956
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. No immediate pain relief for the pharmaceutical industry.
    Ahlborn H, Henderson S, Davies N.
    Curr Opin Drug Discov Devel; 2005 May; 8(3):384-91. PubMed ID: 15892254
    [Abstract] [Full Text] [Related]

  • 18. The epiphany of data warehousing technologies in the pharmaceutical industry.
    Barrett JS, Koprowski SP.
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):S3-13. PubMed ID: 11911607
    [Abstract] [Full Text] [Related]

  • 19. When will the genomics investment pay off for antibacterial discovery?
    Mills SD.
    Biochem Pharmacol; 2006 Mar 30; 71(7):1096-102. PubMed ID: 16387281
    [Abstract] [Full Text] [Related]

  • 20. Antibacterial drug discovery--then, now and the genomics future.
    Monaghan RL, Barrett JF.
    Biochem Pharmacol; 2006 Mar 30; 71(7):901-9. PubMed ID: 16494849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.